Development, Characterization, and Evaluation of Chi-Tn mAb-Functionalized DOTAP-PLGA Hybrid Nanoparticles Loaded with Docetaxel for Lung Cancer Therapy
Open Access
- 25 January 2025
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (2) , 164
Abstract
Background/Objectives: The focus of this study was to prepare and characterize docetaxel (DCX)-loaded lipid/polymer hybrid nanoparticles (LPHNps) functionalized with the monoclonal antibody (mAb) Chi-Tn for a potential active targeting approach in lung cancer treatment. Methods: We synthesized DOTAP-PLGA hybrid nanoparticles loaded with DCX and functionalized them with Chi-Tn mAb through a biotin–avidin approach. The physicochemical characterization involved dynamic light scattering, transmission electron microscopy, Raman spectroscopy, and atomic force microscopy. The in vitro and in vivo evaluations encompassed uptake studies, cell viability tests, and the assessment of tumor growth control in a lung cancer model. Results: The nanoparticles featured a hydrophobic PLGA core with 99.9% DCX encapsulation efficiency, surrounded by a DOTAP lipid shell ensuring colloidal stability with a high positive surface charge. The incorporation of PEGylated lipids on their surface helps evade the immune system and facilitate Chi-Tn mAb attachment. The resulting nanoparticles exhibit a spherical shape with monodisperse particle sizes averaging 250 nm, and demonstrate sustained drug release. In vitro uptake studies and viability assays conducted in A549 cancer cells show that the Chi-Tn mAb enhances nanoparticle internalization and significantly reduces cell viability. In vivo studies demonstrate a notable reduction in tumor volume and an increased survival rate in the A549 tumor xenograft mice model when DCX was encapsulated in nanoparticles and targeted with Chi-Tn mAb in comparison to the free drug. Conclusions: Therefore, Chi-Tn-functionalized LPHNps hold promise as carriers for actively targeting DCX to Tn-expressing carcinomas.Keywords
Funding Information
- CAP (POS_NAC_2015_1_109551)
- ANII (POS_NAC_2015_1_109551)
This publication has 41 references indexed in Scilit:
- Hybrid PEGylated chitosan/PLGA nanoparticles designed as pH-responsive vehicles to promote intracellular drug delivery and cancer chemotherapyInternational Journal of Biological Macromolecules, 2022
- Docetaxel in chitosan-based nanocapsules conjugated with an anti-Tn antigen mouse/human chimeric antibody as a promising targeting strategy of lung tumorsInternational Journal of Biological Macromolecules, 2021
- Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?Cancer Cell, 2019
- Lipid polymer hybrid nanospheres encapsulating antiproliferative agents for stent applicationsJournal of Industrial and Engineering Chemistry, 2016
- Combinatorial prospects of nano-targeted chemoimmunotherapyBiomaterials, 2016
- Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In VivoSmall, 2015
- Tn and sialyl‐Tn antigens, aberrant O‐glycomics as human disease markersProteomics – Clinical Applications, 2013
- Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: Anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsulesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2013
- The Tn Antigen—Structural Simplicity and Biological ComplexityAngewandte Chemie International Edition, 2011
- Spectroscopic Characterisation of Cationic Quaternary Ammonium StarchesStarch - Stärke, 2009